• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Exp Biol Med (Maywood) . Identification of SARS-CoV-2 on the ocular surface in a cohort of COVID-19 patients from Brazil

tetano

Editor, Senior Moderator
Exp Biol Med (Maywood)


. 2021 Jul 19;15353702211024651.
doi: 10.1177/15353702211024651. Online ahead of print.
Identification of SARS-CoV-2 on the ocular surface in a cohort of COVID-19 patients from Brazil


Matheus S Gasparini[SUP] 1 [/SUP], Leandro M Dos Santos[SUP] 1 [/SUP], Ahmad Ma Hamade[SUP] 1 [/SUP], Luísa G Gross[SUP] 1 [/SUP], Arthur P Favarato[SUP] 1 [/SUP], José Pc de Vasconcellos[SUP] 1 [/SUP], Mônica B de Melo[SUP] 2 [/SUP], Pierina L Parise[SUP] 3 [/SUP], Camila L Simeoni[SUP] 3 [/SUP], Natália B Silva[SUP] 4 [/SUP], Marcelo A da Silva Mori[SUP] 5 6 7 [/SUP], André S Vieira[SUP] 8 [/SUP], Alessandro Dos Santos Farias[SUP] 4 [/SUP], Fabiana Granja[SUP] 3 9 [/SUP], Angelica Z Schreiber[SUP] 6 [/SUP], Maria L Moretti[SUP] 7 [/SUP], José L Proença-Modena[SUP] 3 10 [/SUP], Mônica Alves[SUP] 1 [/SUP]



Affiliations

Abstract

In this cross-sectional study, we investigate the presence of Severe Acute Respiratory Syndrome Coronavirus 2 Ribonucleic Acid (SARS-CoV-2 RNA) in the tears of hospitalized COVID-19 patients. After laboratory confirmation of SARS-CoV-2 infection by reverse transcription polymerase chain reaction (RT-PCR) analysis, tear samples from both eyes of each patient were collected using conjunctival swab for RT-PCR. Detailed demographic profile, systemic and ocular symptoms, comorbidities, clinical, ancillary, and ocular manifestations were evaluated. Of the 83 patients enrolled in the study, 7 (8.43%) had SARS-CoV-2 RNA detected in the tear samples. Neutrophils' count, C-reactive protein, and D-dimer were higher in patients with SARS-CoV-2 detected in tears than in patients without virus in ocular surface samples. One patient with SARS-CoV-2 in tears showed mild ocular eyelid edema, hyperemia, and chemosis. No relevant ocular manifestations were detected in the other patients. Although the levels of viral RNA on ocular surface samples were low for most patients (5/7), with positivity only for gene N and CT higher than 30, two patients were positive for all viral targets tested (N, E, and RpRd), with viral load near 1 × 10[SUP]5[/SUP] ePFU/mL, indicating that the ocular transmission of SARS-CoV-2 is a possibility that needs to be considered, especially in the hospital environment. Further studies need to be conducted to demonstrate whether infective viral particles could be isolated from tears.

Keywords: COVID-19; Coronavirus; eye infections; viral.
 
Back
Top Bottom